Placebo + AZD5634
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pulmonary/Respiratory Diseases
Conditions
Pulmonary/Respiratory Diseases
Trial Timeline
May 30, 2017 → Apr 12, 2018
NCT ID
NCT02950805About Placebo + AZD5634
Placebo + AZD5634 is a phase 1 stage product being developed by AstraZeneca for Pulmonary/Respiratory Diseases. The current trial status is completed. This product is registered under clinical trial identifier NCT02950805. Target conditions include Pulmonary/Respiratory Diseases.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02950805 | Phase 1 | Completed |